Published in Women's Health Weekly, December 7th, 2006
"The prevalence of high-risk lesions is equal in women with a BRCA1 or a BRCA2 mutation, but is higher in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.